BG
BMR

Bahl & Gaynor’s BIOMED REALTY TRUST INC BMR Stock Holding History

Bahl & Gaynor’s Portfolio BMR Stock Details BMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-12,450
Closed -$295K – 435
2015
Q4 		$295K Sell
12,450
-25,998
-68% -$605K ﹤0.01% 373
2015
Q3 		$769K Buy
38,448
+1,369
+4% +$27.4K 0.01% 261
2015
Q2 		$717K Buy
37,079
+5,350
+17% +$111K 0.01% 276
2015
Q1 		$719K Buy
31,729
+363
+1% +$8.34K 0.01% 256
2014
Q4 		$676K Buy
+31,366
New +$668K 0.01% 258

Other funds holding BMR

UIC
Uniplan Investment Counsel Milwaukee, Wisconsin $974M AUM 21.37% 1-Year Est. Return
MAM
Mizuho Asset Management Tokyo, Japan $462M AUM 15.39% 1-Year Est. Return
KB
Kimelman & Baird New York $1.35B AUM 25.94% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Bahl & Gaynor's BMR Position: Q1 2016 in Review

Bahl & Gaynor sold out of BIOMED REALTY TRUST INC (BMR) in Q1 2016, closing a stake of 12,450 shares — an estimated $295K sold.

Bahl & Gaynor first reported a position in BMR in Q4 2014 and held it in 5 quarters. The position peaked at $769K in Q3 2015. 4 funds tracked by Wall St. Rank hold BMR as of Q1 2016.

  • Bahl & Gaynor reported no remaining BIOMED REALTY TRUST INC position as of Q1 2016 after selling out during the quarter.
  • Bahl & Gaynor sold 12,450 BIOMED REALTY TRUST INC shares in Q1 2016, an estimated $295K.
  • Bahl & Gaynor first reported a position in BIOMED REALTY TRUST INC in Q4 2014 and held it in 5 quarters.
  • Bahl & Gaynor's BIOMED REALTY TRUST INC position peaked at $769K in Q3 2015.
  • 4 funds tracked by Wall St. Rank held BIOMED REALTY TRUST INC as of Q1 2016.

Based on Bahl & Gaynor's 13F filing for Q1 2016, filed 10 May 2016.